Clinical trial
Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With Granulocyte Colony-stimulating Factor (Filgrastim)
NCT01713309 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With Granulocyte Colony-stimulating Factor (Filgrastim)
- Lead sponsor
- Helsinki University Central Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 31, 1996
- Completion date
- September 30, 1998
- Enrollment
- 59 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute respiratory failure, critically ill